Description: Learn about considerations and industry observed trends which cover different ways companies try to manage their inforce business in low and rapidly rising interest environments. You will explore M&A, block transaction, and offshore reinsurance solutions.

Description: This session will provide an analysis of the latest activities and trends in asset-intensive reinsurance (AIR), including life, annuity, long-term care (LTC), and pension risk transfer (PRT) transactions, and their anticipated impact on the industry in the coming years. Speakers will delve into the strategic considerations of reinsurers, the concerns and preferences of insurers, and the perspectives of rating agencies. Through a case study, the session will demonstrate how asset-intensive reinsurance can serve as a capital lever and profitability enhancer within the evolving regulatory landscape. The discussion will highlight how these strategies support insurers' strategic initiatives, enhance internal rates of return (IRR) and other key performance indicators (KPI), facilitate sales growth and product launches, and improve the financial strength of the company. Additionally, as many of these transactions utilize alternative asset classes to enhance yields, the speakers will examine the differences among these asset classes and the key considerations when incorporating or modeling them in actuarial work.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: This report examines the adoption and challenges of predictive analytics in life and annuity reinsurance, including current practices, regulatory context, and advanced AI applications.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Cayman is a rapidly growing reinsurance domicile with several notable transactions executed in the past few years. We expect this trend to persist as (re)insurers will continue to explore more effective ways to manage their business. In this session, you will gain: - An overview of how the Cayman (re)insurance market has developed over recent years - An introduction to the Cayman regulatory framework - Key considerations for reinsurance structuring and pricing. Join a discussion at the close of the session on the outlook for the Cayman market. You will leave this session with an understanding of the Cayman (re)insurance market, the regulatory framework and key factors that impact reinsurance structuring and pricing.

Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: This session will review reinsurance fundamentals, risk assessment techniques, optimization strategies, and regulatory considerations through case studies and best practices. Attendees will gain insights into enhancing capital management, risk mitigation, and improving operating results, utilizing practical insights from both reinsurers and direct experience. This presentation offers a valuable and practical opportunity to navigate the complexities of reinsurance, optimize transactions, and driving strategic growth in today's dynamic insurance landscape.

Description: "This session will delve into strategic forecasting and unified modeling, an innovative approach that utilizes an orchestration engine to streamline model execution and the forecasting process across various platforms. By leveraging publicly available technology stacks, we will demonstrate how a unified modeling platform can enhance workflows and tackle complex business challenges, providing valuable insights for both actuaries and executives. Additionally, we will explore the potential of a top-down framework to facilitate the rapid analysis of key 'what-if' scenarios, minimizing the need for extensive bottom-up modeling processes. A comprehensive data diagram will illustrate the expansion opportunities, showcasing how this unified modeling framework can scale across an entire organization, supporting strategic initiatives such as mergers and acquisitions, reinsurance transactions, and other capital management strategies. Learning Objectives: Discover a holistic approach to strategic forecasting that aligns with organizational goals Understand the potential of unified modeling to significantly enhance actuarial processes and decision-making capabilities Explore how programming language support unified modeling initiatives across various business functions Identify the benefits and challenges associated with implementing unified modeling within your organization"